{
  "id" : "ss2018_mycosis_fungoides_94448",
  "algorithm" : "eod_public",
  "version" : "1.2",
  "name" : "SS2018: Mycosis Fungoides",
  "title" : "Summary Stage 2018: Mycosis Fungoides",
  "subtitle" : "Summary Stage 2018",
  "notes" : "**Mycosis Fungoides**\n\n9700-9701 (C000-C002, C006, C440-C449, C510-C512, C518-C519, C600-C602, C608-C609, C632) \n\n**Note 1:** The following sources were used in the development of this chapter\n* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)\n* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/)\n* Collaborative Stage Data Collection System, version 02.05:  https://cancerstaging.org/cstage/Pages/default.aspx \n* Chapter 81 *Primary Cutaneous Lymphomas*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.\n\n**Note 2:** For mycosis fungoides of sites other than those above, use the appropriate site-specific schema.\n\n**Note 3:** Code 0 is not applicable for this chapter.\n\n**Note 4:**  All lymph node (regional and distant) involvement is coded as regional lymph node involvement.\n\n**Note 5:** Visceral involvement is metastatic disease and should be questioned in the absence of node or blood involvement.",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30\n\n(5) **Introduction to Hematologic Malignancies**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 931-935\n\n(6) Rosen, S.T., Jaffe, E.S., Leonard, J.P., et al. **Primary Cutaneous Lymphomas**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 967-972",
  "last_modified" : "2018-05-09T15:33:20.119Z",
  "definition" : [ {
    "key" : "ss2018",
    "name" : "SS2018",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  } ],
  "rows" : [ [ "1", "Localized only (localized, NOS)\n- MFCG Stage I\n  + Less than 10% of skin surface, no tumors\n  + Limited to patches, papules, or plaques\n- MFCG Stage II\n  + Greater than or equal to 10% of skin surface, no tumors\n  + Generalized patches, papules, or plaques\n- Not stated whether patches, papules, or plaques\n  + % of body surface not stated, no tumors\n  + Skin involvement, NOS: extent not stated, no tumors" ], [ "2", "Regional by direct extension only\n- MFCG Stage III\n  + Cutaneous tumor, size not stated\n  + Generalized erythroderma (confluence of erythemia) \n     * (greater than 50% of body involved with diffuse redness)\n  + One or more tumors equal to 1 cm or greater\n  + Sezary syndrome\n  + Skin lesion described as tumor less than 1 cm" ], [ "3", "Regional lymph node(s) involved only\n- Both clinically enlarged palpable lymph node(s) (adenopathy) AND\n  + pathologically positive nodes\n- Clinically enlarged palpable lymph node(s) (adenopathy) AND\n  + either pathologically negative nodes or no pathological statement\n- No clinically enlarged palpable lymph node(s) (adenopathy) BUT\n  + pathologically positive lymph node(s)\n- Dutch grade 1-4 OR NCI LN 0-4\n  + Clone positive, negative or unknown\n- Regional lymph node(s), NOS\n  + Lymph node(s), NOS" ], [ "4", "Regional by BOTH direct extension AND regional lymph node(s) involved\n- Codes (2) + (3)" ], [ "7", "Distant site(s) involved\n- Distant site(s) (including further contiguous extension)\n  + MFCG Stage IV\n     * Bone marrow\n     * Involvement by at least one organ outside the skin, nodes, blood, or bone marrow\n     * Liver\n     * Spleen\n     * Visceral (non-cutaneous, extranodal) involvement, pathologically confirmed\n- Distant metastasis, NOS \n  + Carcinomatosis" ], [ "9", "Unknown if extension or metastasis" ] ]
}